Methanol Extract of Young Lantana camara L. Leaves Exhibit Anti-Ovarian Cancer and Anti-Inflammatory Effects via Inhibition of PI3K/AKT/mTOR and MAPK Pathways
- PMID: 41138272
- DOI: 10.1002/cbdv.202501758
Methanol Extract of Young Lantana camara L. Leaves Exhibit Anti-Ovarian Cancer and Anti-Inflammatory Effects via Inhibition of PI3K/AKT/mTOR and MAPK Pathways
Abstract
Lantana camara (LC) L. is a widely distributed plant long used in African and Asian medicine for pain, inflammation, skin disorders, and cancer-related symptoms. Young leaves are often brewed into teas to manage digestive and reproductive conditions, including ovarian inflammation. This study examined the methanol extract of young LC leaves for anti-ovarian cancer and anti-inflammatory potential through modulation of PI3K/AKT/mTOR and RAS/RAF/MEK/ERK (MAPK) pathways. Phytochemical and gas chromatography-mass spectrometry (GC-MS) analyses identified over 30 bioactive compounds, notably oleic acid, pyrazine, and palmitic acid. Anticancer activity was tested on SKOV3 and OVCAR-3 ovarian cancer cells, with MTT assays showing strong cytotoxicity (IC50: 12.6 ± 1.8 and 18.9 ± 2.1 µg/mL), while sparing normal IOSE-80 cells (IC50 > 140 µg/mL). Annexin V-FITC/PI staining indicated enhanced apoptosis, with early and late apoptotic populations reaching 31.4% ± 2.5% and 24.7% ± 3.1%. Western blot confirmed suppression of phosphorylated PI3K, AKT, mTOR, MEK, and ERK. In LPS-stimulated RAW264.7 macrophages, the extract reduced nitric oxide, tumor necrosis factor-alpha (TNF-α) (-43.2%), interleukin (IL)-6 (-39.8%), PGE2 (-47.6%), and cyclooxygenase-2 (COX-2) (p < 0.05). ELISA and immunofluorescence further validated cytokine inhibition. These results indicate that LC leaves possess strong anticancer and anti-inflammatory properties, supporting their traditional use and therapeutic potential against ovarian cancer and inflammation.
Keywords: Lantana camara; MAPK signaling; PI3K/AKT/mTOR pathway; anti‐inflammatory; bioactive compounds; ovarian cancer.
© 2025 Wiley‐VHCA AG, Zurich, Switzerland.
References
-
- S. Jamieson, R. Butzow, N. Andersson, et al., “The FOXL2 C134W Mutation Is Characteristic of Adult Granulosa Cell Tumors of the Ovary,” Modern Pathology 23 (2010): 1477–1485, https://doi.org/10.1038/modpathol.2010.145.
-
- C. Van Haaften, C. C. Duke, A. M. Weerheim, et al., “Potent Cytotoxic Effects of Calomeria amaranthoides on Ovarian Cancers,” Journal of Experimental & Clinical Cancer Research 30 (2011): 29, https://doi.org/10.1186/1756‐9966‐30‐29.
-
- S. Banerjee, S. Nau, S. N. Hochwald, H. Xie, and J. Zhang, “Anticancer Properties and Mechanisms of Botanical Derivatives,” Phytomedicine Plus 3 (2023): 100396, https://doi.org/10.1016/j.phyplu.2022.100396.
-
- A. Pal, S. Sanyal, S. Das, and T. K. Sengupta, “Corrigendum to “Effect of Lantana camara Ethanolic Leaf Extract on Survival and Migration of MDA‐MB‐231 Triple‐Negative Breast Cancer Cell Line”,” Journal of Herbal Medicine 46 (2024): 100910, https://doi.org/10.1016/j.hermed.2024.100910.
-
- M. Zeeshan and M. Kukshal, “A Review of Therapeutic Properties of Lantana camara,” International Journal of Novel Research and Development 8 (2023): d831–d838.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
